Management of oxidative stress and inflammation in cardiovascular diseases: mechanisms and challenges

Thoria Donia1, Abeer Khamis2

  • 1Biochemistry Division, Chemistry Department, Faculty of Science, Tanta University, Tanta, Egypt.

Insights

Oxidative stress and inflammation are key drivers of cardiovascular diseases (CVDs), contributing to plaque formation. This review explores their interplay, biomarkers, lifestyle impacts, and genetic influences on CVD risk.

Area of Science:

  • Biomedical Science
  • Cardiology
  • Molecular Biology

Background:

  • Cardiovascular diseases (CVDs) share common etiologies, notably the interplay of oxidative stress and inflammation.
  • These processes are crucial in the development of atherosclerotic plaques.

Purpose of the Study:

  • To elucidate the crosstalk between oxidative stress, inflammation, and CVD.
  • To review mitochondrial roles, prevention strategies, biomarkers, lifestyle impacts, genetic susceptibility, and omics technologies related to CVD.
  • To explore oxidative stress-related microRNAs and epigenetic modifications.

Main Methods:

  • Literature review focusing on the pathophysiology of CVDs.
  • Analysis of laboratory biomarkers and physiological tests for oxidative stress and inflammation.
  • Exploration of omics technologies and microRNA involvement.

Main Results:

  • A strong link exists between oxidative stress, inflammation, and CVD pathogenesis.
  • Mitochondrial dysfunction plays a role in this crosstalk.
  • Healthy lifestyles can mitigate CVD onset and progression.

Conclusions:

  • Understanding the redox and inflammatory basis of CVD is crucial for prevention.
  • Individual variability in CVD risk is influenced by genetic susceptibility and assessed through advanced omics technologies.
  • Epigenetic modifications and microRNAs are emerging areas in CVD research.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
89
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
581
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
142
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.5K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
45
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
107